Local infusion of the selective 5HT‐1B agonist CP‐93,129 facilitates striatal dopamine release in vivo

This publication has 14 references indexed in Scilit:

• The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study
  Published by Elsevier ,2003
• Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis
  Brain Research, 1993
• Presynaptic dopamine release is enhanced by 5‐HT₃ receptor activation in medial prefrontal cortex of freely moving rats
  Synapse, 1992
• Binding and uptake studies with [3H]CP-93, 129, a radiolabeled selective 5-HT1B receptor ligand
  Drug Development Research, 1992
• Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
  Life Sciences, 1992
• Differential agonist profile of the enantiomers of 3‐PPP at striatal dopamine autoreceptors: Dependence on extracellular dopamine
  Synapse, 1991
• Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis
  Neuropharmacology, 1991
• Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens
  Brain Research, 1991
• 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1*) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole
  Journal of Medicinal Chemistry, 1990
• The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine
  European Journal of Pharmacology, 1989